The Race to 2030
Vision 2030 · Health Sector

The Race to 2030

A scroll-driven look at how Saudi Arabia's health transformation is tracking against its 2030 targets - 0 achieved, 6 on track, across 8 key indicators.

Scroll to begin the story

Health Transformation Funding

Vision 2030 health budget allocation · SAR billions

B SARin 2018
2016 · Vision 2030 launches

A decade-long bet on health

Vision 2030 launched in April 2016 with measurable health targets - but zero dedicated health-transformation funding in Year 1. The real money came next.

The investment ramp

From SAR 12B to SAR 68B in eight years

Dedicated health-transformation spending climbed every budget cycle - financing new hospitals, a larger workforce, digital health infrastructure, and the NPHIES claims exchange.

Outcomes · 1 of 8

Life expectancy is 0.3 years from the 2030 goal

The official series now reports 79.7 years (2025), against a 74.4 baseline and an 80-year goal. Part of the move is a source rebase to a basis near the World Bank estimate - see the methodology note - but the direction is real: primary care and chronic-disease management keep improving.

Workforce · 2 of 8

A homegrown health workforce, nearly doubled

Saudization of the health sector jumped from 19% to 35%, on track for 40% by 2030 - reducing reliance on expatriate staff and building lasting national capacity.

Financing · 3 of 8

Private capital is closing on the target

On a national-health-accounts basis the private sector funds roughly 35% of health spending, approaching the 35% target (the 2024 total is an estimate). Privatization and FDI in healthcare remain a priority, not a finished job.

Capacity · 4 of 8

Doctors and beds are scaling steadily

Physician density reached 2.74 per 1,000 (target 3.0) and primary care centers grew toward the 3,000 goal - expanding access across all 13 regions.

The frontier · at risk

One goal is falling behind: local pharma

Local pharmaceutical manufacturing sits at 22% against a 40% target - the Kingdom still imports most of its medicines. This is the transformation’s hardest, most strategic gap.

The scorecard

Six on track, two at risk

Under the published status rule, six of eight indicators are pacing their 2030 targets. Diabetes joins local pharma manufacturing at risk: only a third of the required reduction has landed with 57% of the time gone. Separately, the 2025 transformation report says regional emergency readiness already hit its 2030 target (92%).

Explore the underlying data

Every figure here is drawn from official MOH and GASTAT statistics. Dive into the full dashboards for demographics, infrastructure, workforce, and finance.

Disclaimer

This platform is an independent, non-commercial data visualization project. It is not affiliated with, endorsed by, or produced by the Ministry of Health of Saudi Arabia, the General Authority for Statistics (GASTAT), the World Bank, the World Health Organization (WHO), or any other government body or institution.

All data presented is sourced exclusively from publicly available official publications, including MOH Statistical Yearbooks, GASTAT health statistics reports, World Bank Open Data, and WHO Global Health Observatory. Statistical figures are reproduced as-is for informational and educational purposes. No personal, patient, or individually identifiable data is collected, stored, or displayed.

While every effort has been made to ensure accuracy, the data may not reflect the most recent figures. Users should refer to the original source publications for authoritative and up-to-date statistics. This platform does not constitute medical, financial, or policy advice.

Data sources: MOH · GASTAT · World Bank · WHO · Last aggregated: May 2026

Healthcare Intelligence Assistant
Trained on Saudi healthcare research & dashboard data

Ask me anything about

Saudi Arabia's healthcare system

Suggested questions

Shift+Enter for new line · Enter to send